AEQUUS PHARMACEUTICALS INC (AQS.CA)
CA0076361033 - Common Stock
AEQUUS PHARMACEUTICALS INC
TSX-V:AQS (9/10/2024, 7:00:00 PM)
0.015
+0 (+50%)
Company Profile
Aequus Pharmaceuticals, Inc. engages in the development and commercialization of alternatives to currently approved drugs. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-03-17. The firm is engaged in the sale and marketing of several commercial products in ophthalmology and transplant. Its pipeline products include Evolve Intensive Gel, Evolve Daily Intensive, SCOPE Portfolio, Zimed PF and REV-0100 / ReVision. Evolve Intensive Gel and Evolve Daily Intensive contains lubricating eye drops intended for use in the relief of discomfort that arises from dry eye sensations, including dryness, soreness, feelings of grit, and irritation. Zimed PF is a preservative-free multi-dose Bimatoprost for glaucoma patients in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. The company plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license.
Company Info
AEQUUS PHARMACEUTICALS INC
Suite 2820, 200 Granville Street
Vancouver BRITISH COLUMBIA V6C 1S4
P: 16043367906
CEO: Douglas Glen Janzen
Employees: 12
Website: https://www.aequuspharma.ca/
AQS.CA News
a year ago - Aequus PharmaceuticalsAequus Reports Second Quarter 2023 Financial Highlights and General UpdateVANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a...
a year ago - Aequus PharmaceuticalsAequus Announces Zimed PF Now Available in CanadaVANCOUVER, British Columbia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a...
a year ago - Aequus PharmaceuticalsAequus Announces Zimed PF Website LaunchVANCOUVER, British Columbia, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a...
a year ago - Aequus PharmaceuticalsAequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in CanadaVANCOUVER, British Columbia, Aug. 18, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), ) (“Aequus” or the “Company”), a...
a year ago - Aequus PharmaceuticalsAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)VANCOUVER, British Columbia, July 06, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”),...
a year ago - Aequus PharmaceuticalsAequus Provides General Update and First Quarter 2023 Financial HighlightsVANCOUVER, British Columbia, May 30, 2023 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a...
AQS.CA Twits
Here you can normally see the latest stock twits on AQS.CA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
